[HTML][HTML] Impact of sacubitril/valsartan on clinical and echocardiographic parameters in heart failure patients with reduced ejection fraction: data from a real life 2-year …
G Armentaro, G D'Arrigo, M Magurno… - Frontiers in …, 2021 - frontiersin.org
Heart failure (HF) represents a widespread health problem characterized by high morbidity
and mortality. Sacubitril/Valsartan (sac/val) has improved clinical prognosis in patients …
and mortality. Sacubitril/Valsartan (sac/val) has improved clinical prognosis in patients …
Impact of Sacubitril/Valsartan on Clinical and Echocardiographic Parameters in Heart Failure Patients With Reduced Ejection Fraction: Data From a Real Life 2-year …
G Armentaro, G D'Arrigo, M Magurno… - FRONTIERS IN …, 2021 - iris.uniroma1.it
Heart failure (HF) represents a widespread health problem characterized by high morbidity
and mortality. Sacubitril/Valsartan (sac/val) has improved clinical prognosis in patients …
and mortality. Sacubitril/Valsartan (sac/val) has improved clinical prognosis in patients …
[HTML][HTML] Impact of Sacubitril/Valsartan on Clinical and Echocardiographic Parameters in Heart Failure Patients With Reduced Ejection Fraction: Data From a Real Life …
G Armentaro, G D'Arrigo, M Magurno… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Heart failure (HF) represents a widespread health problem characterized by high morbidity
and mortality. Sacubitril/Valsartan (sac/val) has improved clinical prognosis in patients …
and mortality. Sacubitril/Valsartan (sac/val) has improved clinical prognosis in patients …
Impact of Sacubitril/Valsartan on Clinical and Echocardiographic Parameters in Heart Failure Patients With Reduced Ejection Fraction: Data From a Real Life 2-year …
G Armentaro, G D'Arrigo, M Magurno… - FRONTIERS IN …, 2021 - iris.unicz.it
Heart failure (HF) represents a widespread health problem characterized by high morbidity
and mortality. Sacubitril/Valsartan (sac/val) has improved clinical prognosis in patients …
and mortality. Sacubitril/Valsartan (sac/val) has improved clinical prognosis in patients …
Impact of Sacubitril/Valsartan on Clinical and Echocardiographic Parameters in Heart Failure Patients With Reduced Ejection Fraction: Data From a Real Life 2-year …
G Armentaro, G D'Arrigo, M Magurno… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Heart failure (HF) represents a widespread health problem characterized by high morbidity
and mortality. Sacubitril/Valsartan (sac/val) has improved clinical prognosis in patients …
and mortality. Sacubitril/Valsartan (sac/val) has improved clinical prognosis in patients …
Impact of Sacubitril/Valsartan on Clinical and Echocardiographic Parameters in Heart Failure Patients With Reduced Ejection Fraction: Data From a Real Life 2-year …
G Armentaro, G D'Arrigo, M Magurno… - Frontiers in …, 2021 - europepmc.org
Heart failure (HF) represents a widespread health problem characterized by high morbidity
and mortality. Sacubitril/Valsartan (sac/val) has improved clinical prognosis in patients …
and mortality. Sacubitril/Valsartan (sac/val) has improved clinical prognosis in patients …
[PDF][PDF] Impact of Sacubitril/Valsartan on Clinical and Echocardiographic Parameters in Heart Failure Patients With Reduced Ejection Fraction: Data From a Real Life 2 …
G Armentaro, G D'Arrigo, M Magurno… - … in Pharmacology| www …, 2021 - iris.uniroma1.it
Heart failure (HF) represents a widespread health problem characterized by high morbidity
and mortality. Sacubitril/Valsartan (sac/val) has improved clinical prognosis in patients …
and mortality. Sacubitril/Valsartan (sac/val) has improved clinical prognosis in patients …